FindTrial
Sign In

SHR-1316 Injection

DRUG5 trials

Sponsors

Suzhou Suncadia Biopharmaceuticals Co., Ltd., Shanghai Shengdi Pharmaceutical Co., Ltd, Shanghai Hengrui Pharmaceutical Co., Ltd.

Conditions

Advanced Cervical CancerMalignant Solid TumorsPD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast CancerSolid TumorWidespread Small Cell Lung Cancer

Phase 1

Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer
RecruitingNCT07009457
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Widespread Small Cell Lung Cancer
Start: 2025-06-16End: 2028-09-30Target: 48Updated: 2025-07-04
A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
RecruitingNCT07229586
Shanghai Hengrui Pharmaceutical Co., Ltd.Solid Tumor
Start: 2025-12-02End: 2027-12-31Target: 100Updated: 2025-12-19

Phase 2

A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors
RecruitingNCT07268040
Shanghai Hengrui Pharmaceutical Co., Ltd.Malignant Solid Tumors
Start: 2025-12-23End: 2028-12-31Target: 400Updated: 2026-01-12

Phase 3

A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
RecruitingNCT07111832
Suzhou Suncadia Biopharmaceuticals Co., Ltd.PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer
Start: 2025-08-20End: 2028-12-31Target: 400Updated: 2025-12-18
A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer
RecruitingNCT07168200
Shanghai Shengdi Pharmaceutical Co., LtdAdvanced Cervical Cancer
Start: 2025-10-17End: 2028-12-31Target: 720Updated: 2025-11-17